SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, Inovio’s CEO, presented keynote remarks at MIT’s Emerging Technologies Conference hosted by the Massachusetts Institute of Technology. (Read Dr. Kim’s speech.)
